California-based drugmaker takes advantage of surging share price to strike takeovers
ICE Raids and Medicaid Cuts Put Both Caregivers and Their Patients at Risk
...
Read moreDetailsHome » Gilead buys autoimmune biotech Ouro Medicines for $2.2bn
California-based drugmaker takes advantage of surging share price to strike takeovers
...
Read moreDetails...
Read moreDetails